Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Epidemiology and Infection|October 1, 1987
Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrationsJ A Sáez-Nieto, D Fontanals, J Garcia de Jalon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 studyA Necchi, R W Joseph, Y Loriot, et al.
British Journal of Cancer|March 12, 2009
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytesC Alfaro, N Suarez, A Gonzalez, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 18, 2009
Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association studyJ Velasco, M T Zarrabeitia, J R Prieto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trialsJ L Perez-Gracia, N Penel, E Calvo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2016
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic valueE Alegre, J P Fusco, P Restituto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2017
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patientsM F Sanmamed, J L Perez-Gracia, K A Schalper, et al.
ESMO Open|August 30, 2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II studyA Rodriguez-Vida, B P Valderrama, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2018
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patientsM E Rodríguez-Ruiz, J L Perez-Gracia, I Rodríguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)J Bellmunt, J M Kerst, F Vázquez, et al.
Pageof 14